Trial Profile
Clopidogrel Pharmacogenetics Bench to Bedside - A Practical Application.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Oct 2023
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Omeprazole
- Indications Acute coronary syndromes; Angina pectoris; Atherosclerosis; Cardiovascular disorders; Coronary thrombosis; Ischaemic heart disorders; Myocardial infarction; Peripheral arterial occlusive disorders; Stroke
- Focus Pharmacodynamics; Pharmacogenomic
- Acronyms PGXB2B
- 28 Apr 2011 New trial record